Overview of Diclofenac Sodium
Diclofenac sodium, identified by the National Drug Code (NDC) 76282-0103, is a nonsteroidal anti-inflammatory drug (NSAID) manufactured by Exelan Pharmaceuticals, Inc.[1].
Market Context
Diclofenac sodium is widely used for its anti-inflammatory, analgesic, and antipyretic properties, making it a staple in the treatment of various conditions such as arthritis, pain, and inflammation.
Current Market Status
- Demand and Usage: Diclofenac sodium remains a popular choice among healthcare providers due to its efficacy and relatively low cost compared to newer, more expensive alternatives. This consistent demand ensures a stable market presence.
- Competitive Landscape: The NSAID market is highly competitive, with multiple manufacturers producing diclofenac sodium. However, Exelan Pharmaceuticals, Inc. maintains a significant share due to its established distribution channels and pricing strategies[1].
Price Projections
Factors Influencing Pricing
- Generic Competition: As a generic drug, diclofenac sodium faces intense competition from other generic manufacturers. This competition tends to keep prices stable or slightly decreasing over time.
- Regulatory Environment: Pricing is also influenced by regulatory policies and reimbursement schemes. For instance, changes in Medicare and Medicaid reimbursement rates can impact the overall pricing strategy[5].
- Manufacturing Costs: Fluctuations in raw material costs and manufacturing expenses can affect the final price of the drug.
Current Pricing
As of the latest data, the pricing for diclofenac sodium (NDC 76282-0103) is generally competitive with other generic NSAIDs on the market. The exact price can vary depending on the pharmacy, location, and any applicable discounts or insurance coverage.
Future Pricing Trends
- Stable Pricing: Given the generic nature of the drug, it is likely that the price will remain relatively stable. Any significant price increases are unlikely due to the competitive nature of the generic drug market.
- Potential Decreases: With the ongoing competition and the possibility of new entrants into the market, there could be slight decreases in price over the next few years.
Market Analysis
Market Size and Growth
The NSAID market, which includes diclofenac sodium, is substantial and continues to grow, albeit at a moderate pace. The global NSAID market is driven by the increasing prevalence of chronic pain and inflammatory conditions.
Segment Analysis
- Prescription vs. OTC: Diclofenac sodium is available in both prescription and over-the-counter (OTC) forms. The prescription segment tends to have more stable pricing due to regulatory oversight, while OTC pricing can be more volatile based on consumer demand and competition.
- Geographical Segmentation: Pricing can vary significantly across different regions due to local regulatory environments, healthcare policies, and market dynamics.
Challenges and Opportunities
Challenges
- Generic Competition: The primary challenge for Exelan Pharmaceuticals, Inc. is the intense competition from other generic manufacturers. This competition can lead to price wars and reduced profit margins.
- Regulatory Hurdles: Changes in regulatory policies, especially those related to pricing and reimbursement, can impact the profitability of the drug.
Opportunities
- Expanding Distribution Channels: Expanding distribution channels, particularly in emerging markets, can increase the market share and revenue for diclofenac sodium.
- Combination Therapies: There is an opportunity to explore combination therapies that include diclofenac sodium, which could enhance its market value and pricing potential.
Key Takeaways
- Stable Demand: Diclofenac sodium continues to enjoy stable demand due to its efficacy and widespread use.
- Competitive Pricing: The drug is priced competitively within the generic NSAID market.
- Regulatory Influence: Pricing is significantly influenced by regulatory and reimbursement policies.
- Future Trends: The price is likely to remain stable, with potential for slight decreases due to competition.
FAQs
Q: What is the current market status of diclofenac sodium (NDC 76282-0103)?
A: Diclofenac sodium remains a widely used NSAID with stable demand and competitive pricing.
Q: How does generic competition affect the pricing of diclofenac sodium?
A: Generic competition keeps prices stable or slightly decreasing over time due to the intense competition among manufacturers.
Q: What regulatory factors influence the pricing of diclofenac sodium?
A: Regulatory policies, especially those related to reimbursement schemes and Medicare/Medicaid rates, significantly influence the pricing.
Q: Are there opportunities for price increases for diclofenac sodium?
A: Significant price increases are unlikely due to the competitive nature of the generic drug market.
Q: How can Exelan Pharmaceuticals, Inc. expand its market share for diclofenac sodium?
A: Expanding distribution channels, particularly in emerging markets, and exploring combination therapies could increase market share and revenue.
Sources
- FindACode: EXELAN PHARMACEUTICALS, INC. - List of Drugs - NDC Labeler...
- CMS: NDC LIST 8_17_20 - CMS
- Drug-Dev: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
- FDA: National Drug Code Directory - FDA
- CMS: Drug Name and National Drug Code (NDC) Reference Data Instructions Calendar Year 2024
